Drug Shortage Report for MINT-IRBESARTAN/HCTZ

Last updated on 2019-01-16
Report ID 71060
Drug Identification Number 02393018
Brand name MINT-IRBESARTAN/HCTZ
Common or Proper name Irbesartan- Hydrochlorothiazide
Company Name MINT PHARMACEUTICALS INC
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 300.0MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 count bottles
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-01-03
Estimated end date 2019-02-15
Actual end date 2019-01-14
Shortage status Resolved
Updated date 2019-01-16
Company comments
Health Canada comments
Contact Address 1093 MEYERSIDE DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 1J6
Company contact information